International Patent: DRUG AND METHOD FOR ELIMINATING CCCDNA FROM LIVER OF PATIENT INFECTED WITH HEPATITIS B VIRUS

GENEVA, June 26 -- SHANGHAI HEP PHARMACEUTICAL CO., LTD. filed a patent application (CN2025/139219) for “DRUG AND METHOD FOR ELIMINATING CCCDNA FROM LIVER OF PATIENT INFECTED WITH HEPATITIS B VIRUS”. With publication no. WO/2026/119105, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 45/06

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....